Scaling-up the manufacturing of well-characterized mesenchymal stromal cell-derived extracellular vesicles for biomedical applications

The platform established herein could be applied to the production of well-characterized SPC-EVs targeting their biomedical use in different settings (e.g. as drug delivery systems), as well as EVs from other parental cells lines (i.e. dendritic cells) in therapeutic settings as cancer.

Bibliographic Details
Main Author: Fernandes, Ana (author)
Other Authors: Rosa, Sara (author), Silva, Ricardo (author), Cunha, Raquel M. S. (author), Fuzeta, Miguel de Almeida (author), Calado, Cecília (author), Carvalho, Carla (author), Cabral, Joaquim M.S. (author), Azevedo, Ana (author), Silva, Cláudia (author)
Format: conferenceObject
Language:eng
Published: 2022
Subjects:
Stem/progenitor cells-derived extracellular vesicles (SPC-EVs)
Manufacturing platform
Online Access:http://hdl.handle.net/10400.21/14398
Country:Portugal
Oai:oai:repositorio.ipl.pt:10400.21/14398

Internet

http://hdl.handle.net/10400.21/14398

Similar Items